Meloxicam: Clinical Trials

21 trials of Meloxicam, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 completed, 2 unknown. 21 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 121Completed 19, Unknown 2

Follow Meloxicam: new trials by email Literature Review of Meloxicam trials Research Report on Meloxicam

Trials (filtered) newest first · largest first

All 21 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Compare Pharmacokinetics and Safety of JP-1366 Between Korean and Caucasian
coadministration of JP-1366 and aceclofenac, coadministration of JP-1366 and meloxicam, coadministration of JP-1366 and naproxen - Anti-Ulcer Agents
Phase 1CompletedOnconic Therapeutics Inc.882021-03-052022-06-30
Drug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDs
DWP14012, Celecoxib, Naproxen - Healthy Male Volunteers
Phase 1UnknownDaewoong Pharmaceutical Co. LTD.1102020-06-192020-07-29
Pharmacokinetic and Tolerance Study of Meloxicam Eye Drops in Healthy Volunteers
Meloxicam - Healthy Volunteers
Phase 1UnknownBeijing Tongren Hospital802019-12-162020-04-28
A Study to Compare the Amount of Meloxicam in the Blood When it is Taken as Capsules or as Tablets
Meloxicam Capsule (Test), Meloxicam Tablet (Reference) - Healthy
Phase 1CompletedBoehringer Ingelheim262018-10-052019-11-22
On Demand Contraception: Ulipristal Acetate Plus a COX-2 Inhibitor at Peak Fertility
Ulipristal Acetate 30 MG Oral Tablet - Contraception
Phase 1CompletedStanford University122018-03-152019-06-25
Fasting Comparative Bioavailability Study of 2 Meloxicam 15 mg Tablets in Healthy Volunteers Under Fasting Condition
Reumoxicam® 15 mg tablets (PJSC "Farmak", Ukraine), Movalis 15 mg tablets ("Boehringer Ingelheim Ellas A.E.", Greece) - Pharmacokinetics
Phase 1CompletedJoint Stock Company "Farmak"242014-01-292021-11-18
Assessment of a Vaginal Ring With Meloxicam on Ovarian Cycle in Fertile Women
Meloxicam 2.4 g, Meloxicam 3.0 g - Contraception, Bleeding Pattern
Phase 1CompletedLaboratorios Andromaco S.A.132013-01-152019-04-30
Bioequivalence Study of Meloxicam Capsules 15 mg (Mobic® Capsules 15 mg) Versus Meloxicam Tablets 15 mg (Mobic® Tablets 15 mg) in Healthy Adult Volunteers
Meloxicam capsule, Meloxicam tablet - Healthy
Phase 1CompletedBoehringer Ingelheim62008-11-012014-07-08
Aspirin Resistance in Systemic Lupus Erythematosus (SLE)
aspirin and meloxicam - Systemic Lupus Erythematosus
Phase 1CompletedVanderbilt University702005-04-012017-08-07
Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition
Meloxicam - Healthy
Phase 1CompletedDr. Reddy's Laboratories Limited282004-10-012010-07-13
Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition
Meloxicam - Healthy
Phase 1CompletedDr. Reddy's Laboratories Limited282004-09-012010-07-13
Food Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg
Meloxicam Tablets 15 mg, Mobic® Tablets 15 mg - Healthy
Phase 1CompletedMylan Pharmaceuticals Inc272004-08-012024-04-24
Fasting Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg
Meloxicam Tablets 15 mg, Mobic® Tablets 15 mg - Healthy
Phase 1CompletedMylan Pharmaceuticals Inc302004-08-012024-04-24
Meloxicam 15 mg Tablets Under Fasting Conditions
Meloxicam 15 mg Tablets, Mobic® 15 mg Tablets - Healthy
Phase 1CompletedTeva Pharmaceuticals USA282004-02-012024-08-19
Meloxicam 15 mg Tablets Under Non-Fasting Conditions
Meloxicam 15 mg Tablets, Mobic® 15 mg Tablets - Healthy
Phase 1CompletedTeva Pharmaceuticals USA282004-02-012024-08-19
Effect of Steady State Meloxicam on Low Dose Aspirin Induced Inhibition of Platelet Aggregation and Thromboxane Synthesis in Healthy Males and Females
Meloxicam, Aspirin - Healthy
Phase 1CompletedBoehringer Ingelheim162002-07-012014-07-14
Effect of Food on the Pharmacokinetics of Meloxicam in Healthy Volunteers
Meloxicam, low dose, Meloxicam, medium dose, Meloxicam, high dose - Healthy
Phase 1CompletedBoehringer Ingelheim242002-01-012014-07-08
Study to Assess the Effect of Food on the Pharmacokinetics of Meloxicam After Single Administration and to Investigate Dose-proportionality Over a Dosage Range
Meloxicam - low dose, Meloxicam - medium dose, Meloxicam - high dose - Healthy
Phase 1CompletedBoehringer Ingelheim242001-06-012014-07-08
Study of Relative Bioavailability of Mobic Manufactured in China in Comparison With Mobic Manufactured in Germany in Chinese Healthy Volunteers
Mobic, China, 7.5 mg, Mobic, Germany, 7.5 mg - Healthy
Phase 1CompletedBoehringer Ingelheim202001-03-012014-07-08
Pharmacokinetics and Tolerability of Meloxicam Injected Intramuscularly vs. Tablet in Healthy Subjects
Meloxicam ampoule, Meloxicam tablet - Healthy
Phase 1CompletedBoehringer Ingelheim121998-11-012014-07-08

Showing 20 of 21. Sign in to see all of them.

Conditions studied

Lupus Erythematosus, Systemic (1)

Sponsors

Boehringer Ingelheim (8)  ·  Dr. Reddy's Laboratories Limited (2)  ·  Mylan Pharmaceuticals Inc (2)  ·  Teva Pharmaceuticals USA (2)  ·  Beijing Tongren Hospital (1)  ·  Daewoong Pharmaceutical Co. LTD. (1)  ·  Joint Stock Company "Farmak" (1)  ·  Laboratorios Andromaco S.A. (1)  ·  Onconic Therapeutics Inc. (1)  ·  Stanford University (1)  ·  Vanderbilt University (1)

Countries

Canada (4)  ·  United States (4)  ·  South Korea (2)  ·  Chile (1)  ·  China (1)  ·  Russia (1)

Top investigators

Deepen M Patel, M.D., C.C.F.P. (2)  ·  Dorian Williams, M.D. (2)  ·  Paul Y. Tam, M.D. (2)  ·  C M Stein, M.D. (1)  ·  Jang In-Jin, MD, PhD (1)  ·  Vlad Udovytskyi (1)  ·  Xiuli Zhao, Ph.D. (1)

Results publications

PMID 24022862, PMID 35470225, PMID 38700290

NIH funding

R01HL065082 (1)